Johnson & Johnson vs. Pfizer Inc.
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| JNJ | PFE | |
|---|---|---|
| Market Cap | $609.54 billion | $158.45 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | PFE | |
|---|---|---|
| Dividend Yield | 2.12% | 6.19% |
PFE leads on 1 of 1 dividend factors.
Risk & Sentiment
| JNJ | PFE | |
|---|---|---|
| Short Interest | 0.67% | 0.88% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, PFE overview, PFE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
